G6PD deficient cells and the bioreduction of disulfides: Effects of DHEA, GSH depletion and phenylarsine oxide

Biochemical and Biophysical Research Communications

Volumn 273, Issue 3, 2000, Pages 846-852

  Biaglow, John E ^a   Ayene, Iraimoudi S ^a   Koch, Cameron J ^a   Donahue, Jerry ^a   Stamato, Thomas D ^a   Tuttle, Stephen W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENOSOBENZENE; DISULFIDE; GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; PRASTERONE; THIOL;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME DEFICIENCY; MAMMAL CELL; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REDUCTION;

EID: 0034647570     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.3024     Document Type: Article

References (37)

1. Yagi T., Hatefi H. Thiols in oxidative phosphorylation: Inhibition and energy-potentiated uncoupling by monothiol and dithiol modifiers. Biochemistry. 11:1984;24449-24455.
2. Voet D., Voet J. G. Biochemistry. 1995;John Wiley & Sons, Inc. New York.
3. Jakoby W. B. Colowick S., Kaplan N. O. Detoxification and drug metabolism: Conjugation and related systems. Methods of Enzymology. 1981;Academic Press, New York.
4. Sen C. K. Redox signaling and the emerging therapeutic potential for thiol antioxidants. Biochem. Pharmacol. 55:1998;1747-1758.
5. Nakamura H., Nakamura K., Yodoi J. Redox regulation of cellular activation. Annu. Rev. Immunol. 15:1997;351-360.
6. Mustacich D., Powis G. Thioredoxin reductase. Biochem. J. 346:2000;1-8.
7. Tuttle S. W., Varnes M. E., Mitchell J. B., Biaglow J. E. Sensitivity to chemical oxidants and radiation in CHO cells deficient in oxidative pentose cycle activity. Int. J. Radiation Oncol. Biol. Phys. 22:1992;671-675.
8. Held K. D., Tuttle S. W., Biaglow J. E. Role of the pentose cycle in oxygen radical-mediated toxicity of the thiol-containing radioprotector dithiothreitol in mammalian cells. Radiation Res. 134:1993;383-389.
9. Tuttle S. W., Hazard L., Koch C. J., Mitchell J. B., Coleman N., Biaglow J. E. Bioreductive metabolism of SR-4233 (WIN 59075) by whole cell suspensions under aerobic and hypoxic conditions: Role of pentose cycle and implications for mechanism of cytotoxicity observed in air. Int. J. Radiation Oncol. Biol. Phys. 29:1994;357-362.
10. Varnes M. E., Tuttle S. W., Biaglow J. E. Nitroheterocyclic metabolites in mammalian cells: Stimulation of the hexose monophosphate shunt. Biochem. Pharmacol. 33:1984;1671-1677.
11. Tuttle S. W., Stamato T., Perez M. L., Biaglow J. E. Glucose-6-phosphate dehydrogenase and the oxidative pentose phosphate cycle protect cells against apoptosis induced by low doses of ionizing radiation. Radiation Res. 2000.
12. Ayene I. S., Koch C. J., Tuttle S. W., Stamato T. D., Louis Perez M., Biaglow J. E. Altered cellular redox inhibits DNA double strand breaks in G6PD deficient mutants. Int. J. Radiation Biol. 2000.
13. Biaglow J. E., Donahue J., Tuttle S., Held K., Chrestensen C., Mieyal J. J. A method for measuring disulfide reduction by cultured mammalian cells: Relative contributions of GSH dependent and independent mechanisms. Anal. Biochem. 2000.
14. 2 uptake of the R323O AC tumor cells. Adv. Exptl. Med. Biol. 2000.
15. Biaglow J. E., Ayene I. S., Donahue J., Koch C. J., Stamato T. D., Tuttle S. W. Disulfide induced redox alterations radiosensitizes glucose-6-phosphate dehydrogenase deficient cells. 2000.
16. Voet D., Voet J. G. Biochemistry. 1995;John Wiley & Sons, Inc. New York.
17. Mitchell J. B., Russo A., Biaglow J. E. Role of glutathione and other endogenous thiols in radiation response. Pharmacol. Ther. 39:1988;269-274.
18. Biaglow J. E., Nygaard O. F. The use of the oxidant diamide for studying the non-mitochondrial reducing capacity of Ehrlich ascites tumor cells. Biochem. Biophys. Res. Commun. 54:1973;874-881.
19. Biaglow J. E., Clark E. P., Epp E. R., Morse-Gaudio M., Varnes M. E., Mitchell J. B. Non-protein thiols and the radiation response of A549 human lung carcinoma cells. Int. J. Radiat. Biol. 44:1983;489-495.
20. Joshi S., Hughes J. B. Inhibition of coupling factor B activity by cadmium ion, arsenite-2,3-dimercaptopropanol, and phenylarsine oxide, and preferential reaction by dithiols. J. Biol. Chem. 256:1981;11112-11116.
21. Bjornstedt M., Kumar S., Holmgren A. Selenite and selenodiglutathione: Reactions with thioredoxin systems. Methods Enzymol. 252-P:1995;209-219.
22. Stewart M. S., Spalholtz J. E., Needle K. H., Pende B. C. Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis. Free Radical. Biol. Med. 26:1999;42-48.
23. Webb J. L. Enzyme and Metabolic Inhibitors. 1966;Academic Press, New York. p. 602-656.
24. Dworkin C. R., Schwartz H. Inhibition of growth of HeLa and WI-38 cells by dehydroepiandrosterone and its reversal by ribo- and deoxyribonucleosides. Life Sci. 38:1986;1451-1457.
25. Khan S. A., Nyce J. W. Effects of ubiquinone and mevalonate on hepatic peroxisomal enzymes induced by dehydroepiandrosterone. Pharmacol. Toxicol. 80:1997;118-121.
26. Manoco D., Pizzini A., Gato V., Leonardi L., Gallo M., Brignardello E., Boccuzzi G. Role of glucose-6-phosphate dehydrogenase inhibition in the antiproliferative effects of dehydroepiandrosterone on human breast cancer cells. Br. J. Cancer. 75:1997;589-592.
27. Miller R. M., Park E. M., Thomas J. A. Reduction (dethiolation) of protein mixed disulfides; distribution and specificity of dethiolating enzymes and N, N′-bis (2-chloroethyl)-N-nitrosourea inhibition of an NADPH-dependent cardiac dethiolase. Arch. Biochem. Biophys. 15:1991;112-120.
28. Boros L. G., Puigjaner J., Cascante M., Lee W. N., Brandes J. L., Bassilian S., Yasuf F. I., Williams R. D., Muscarella P., Melvin W. S., Schirmer J. W. J. Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. Cancer Res. 19:1997;4242-4248.
29. Banki K., Hutter E., Columbo W., Gonchoroff N. J., Perl A. Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression. J. Biol. Chem. 271:1996;32994-33001.
30. Powis G., Briehl M., Oblong J. Redox signaling and the control of cell growth and death. Pharmacol. Ther. 68:1995;149-173.
31. Powis, G, Gasdaska, J. R, and, Baker, A. 1997, Redox signaling and the control of cell growth and death, pp, 329, - 359, Academic Press, New York.
32. Mieyal J. J., Gravina S. A., Mieyal P. A., Srinivaan U., Stark D. W. Glutathionyl specificity of thioltransferase: mechanistic and physiological implications. Packer L., Cardenas E. Biothiols in Health and Disease. 1995;305-372 Marcel Decker, Inc. New York.
33. Gravina S. A., Mieyal J. Thioltransferase is a specific glutathionyl mixed disulfide oxidoreductase. Biochemistry. 32:1993;3368-3376.
34. Ziegler D. M. Role of reversible oxidation reduction of enzyme thiol-disulfides in metabolic regulation. Ann. Rev. Biochem. 54:1985;305-329.
35. Holmgren A. Thioredoxin and glutaredoxin systems. J. Biol. Chem. 364:1989;13963-13967.
36. Dashtaki R. Dehydroepiandrosterone and analogs inhibit DNA binding to AP-1 and airway smooth muscle proliferation. J. Pharmacol. Exp. Ther. 285:1988;876-883.
37. Pascale R. M., Simile M. M., De Miglio M. R., Nufris A., Scddaiu M. A., Muroni M. R., Danni O., Roa K. N., Feo F. Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase activity and gene expression by dehydroepiandrosterone in preneoplastic liver nodules. Carcinogenesis. 16:1995;1537-1542.